ir vikingtherapeutics.com

Viking Therapeutics Investors Overview

Novel therapeutics for metabolic and endocrine disorders.
traffic

OVERVIEW

This site ir.vikingtherapeutics.com presently has an average traffic classification of zero (the lower the superior). We have explored zero pages within the web site ir.vikingtherapeutics.com and found sixty-two websites associating themselves with ir.vikingtherapeutics.com.
Links to this site
62

IR.VIKINGTHERAPEUTICS.COM RANKINGS

This site ir.vikingtherapeutics.com is seeing alternating levels of traffic for the duration of the year.
Traffic for ir.vikingtherapeutics.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for ir.vikingtherapeutics.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for ir.vikingtherapeutics.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO WEB SITE

Viking Therapeutics

Thyroid beta Agonists for Lipid Disorders. VK0612 for Type 2 Diabetes. Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.

WHAT DOES IR.VIKINGTHERAPEUTICS.COM LOOK LIKE?

Desktop Screenshot of ir.vikingtherapeutics.com Mobile Screenshot of ir.vikingtherapeutics.com Tablet Screenshot of ir.vikingtherapeutics.com

IR.VIKINGTHERAPEUTICS.COM HOST

We revealed that a single root page on ir.vikingtherapeutics.com took one thousand five hundred and sixty milliseconds to come up. Our crawlers could not find a SSL certificate, so in conclusion our crawlers consider ir.vikingtherapeutics.com not secure.
Load time
1.56 secs
SSL
NOT SECURE
Internet Protocol
23.0.160.10

WEBSITE IMAGE

PAGE TITLE

Viking Therapeutics Investors Overview

DESCRIPTION

Novel therapeutics for metabolic and endocrine disorders.

CONTENT

This site states the following, "Thyroid beta Agonists for Lipid Disorders." We noticed that the web site also stated " VK0612 for Type 2 Diabetes." It also stated " Data as of 081715 359 pm ET. Viking Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update. Viking Therapeutics to Conduct Phase 2 Trial of VK2809 in Patients With Cholesterolemia and Fatty Liver Disease. SAN DIEGO, CA - Marketwired - 071415 - Viking Therapeutics, Inc. Viking NASDAQ VKTX, a clinical-stage biopharmaceutical ."

SEEK MORE BUSINESSES

Kadis diary

No vaadake seda viljapõlluga pilti ja öelge, et see pole imetabane? Silma peal hoides näeb nii mõndagi oluliselt varem. Keskendun rohkem lõputööle ning lükkan selleks kuuks kõrvale kõik ülejäänud kohustused. Ideaalis võiks ju nominaalajaga lõpetada.

Can I give more?

Mina loen, loe sina ka. The more you scratch the more you itch. The Significance of Realm of the Mad God Hacks. Visa hing Kilingi-Nõmmelt ja totakuse diskursus. Sulle, talle, endale. Head Uut Aastat Sõbrad! Mind ei ole kodus! Kai and Epu seiklused. Sunday, April 7, 2013. Pika hambaga proovisin ära ka sojatooted ja päris ausalt, mulle meeldib! Minu suur hirm oli v.

Between Me and Thee

Wednesday, 27 June 2012. The last lap of Year 2. Piles of assignments and projects are waiting at one corner of my desk and I could assure you that none of them are gonna be easy. One project would have three deadlines to meet and imagine having about a few of them all taking place at the same time. I really need to pass this semester to pull up my dying GPA.

Shadow Cutlery

Axe of Ragnar - Limited Edition. Home of the History Channels Licensed Telivesion Props. For the latest news and product specials, sign up for our newsletter. Powered by Want a Better Website, Inc.